Brachytherapy may proceed safely in cervical cancer patients following uterine perforation

Brachytherapy may proceed safely in cervical cancer patients following uterine perforation
A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells, may continue safely, potentially without delay or antibiotics, in cervical cancer patients following uterine perforation.
According to the World Health Organization, cervical cancer is the fourth most common cancer in women. Treatment for cervical cancer often involves brachytherapy combined with daily radiation therapy.
Brachytherapy delivers radiation directly to cancer cells through a tube placed within the uterus.
At times this tube can pierce the uterus and lead to a perforation. Many clinicians will not proceed with the treatment when a perforation occurs. This can lead to delays in therapy that may increase the recurrence risk and potentially lead to worse survival rates."

Related Keywords

Emily Henderson ,Loyola University Chicago Stritch School Of Medicine ,World Health Organization ,Loyola University Medical Center ,Loyola Cardinal Bernardin Cancer Center ,Loyola Medicine ,Loyola University Chicago Stritch School ,Loyola University Medical ,National Cancer Institute ,Common Terminology Criteria ,Adverse Events Version ,Cardinal Bernardin Cancer ,Brachytherapy ,Dancer ,Cervical Cancer ,Healthcare ,Hospital ,Implants ,Medicine ,Next Generation ,Nursing ,Ncology ,Radiation Therapy ,Uterus ,எமிலி ஹென்டர்சன் ,லயோலா பல்கலைக்கழகம் சிகாகோ தையல் பள்ளி ஆஃப் மருந்து ,உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,லயோலா பல்கலைக்கழகம் மருத்துவ மையம் ,லயோலா மருந்து ,லயோலா பல்கலைக்கழகம் சிகாகோ தையல் பள்ளி ,லயோலா பல்கலைக்கழகம் மருத்துவ ,தேசிய புற்றுநோய் நிறுவனம் ,பொதுவானது சொல் அளவுகோல்கள் ,